Riskpilot← Back to searchSign inGet full accessAspeca AB
ABActiveOrg 5563098564Drottninggatan 42 APhysiotherapy activities · NACE 8695Est. 19871-4 employees
Revenue 2025
SEK 3,1M
+17% vs 2024
EBITDA margin
32.2%
-30% vs 2024
Equity ratio
89.6%
Financial strength
Net profit 2025
SEK 733K
-29% vs 2024
| Revenue | SEK 3,1M | +17% |
| EBITDA | SEK 1M | -30% |
| Net profit | SEK 733K | -29% |
| Total assets | SEK 4,4M | -6% |
| Equity | SEK 3,9M | +9% |
| Employees | — | — |
Legal name
Aspeca AB
Org number
5563098564
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
26 oktober 1987
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget skall bedriva verksamhet inom allmän sjukgymnastik, konsultverksamhet och utbildning inom företagshälsovård och ekonomi, produktutveckling inom ergonomi och hälsa, köp och försäljning av medicinsk utrustning och hälsoprodukter, köp och försäljning av värdepapper samt därmed förenliga verksamheter.
Address
Drottninggatan 42 A
Phone
+4622731684
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 870 | 2 400 | 2 679 | 2 654 | 3 104 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 808 | 924 | 881 | 1 421 | 1 001 |
| Depreciation & amort. | −57 | −44 | −66 | −67 | −67 |
| EBIT | 751 | 880 | 815 | 1 354 | 934 |
| Net financials | −32 | −27 | −25 | −11 | 2 |
| Profit before tax | 750 | 850 | 695 | 1 297 | 924 |
| Tax | −157 | −170 | −150 | −269 | −191 |
| Net profit | 593 | 680 | 545 | 1 028 | 733 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 545 | 4 224 | 4 301 | 4 642 | 4 360 |
| Equity | 1 892 | 2 393 | 2 744 | 3 577 | 3 908 |
| Long-term debt | 1 521 | 1 489 | 728 | 714 | 0 |
| Short-term debt | 126 | 333 | 724 | 200 | 289 |
| Total debt | 1 647 | 1 822 | 1 452 | 914 | 289 |
EBITDA margin
32.2%
This company
15.8%
Market median
+104% vs market
20212025
Equity ratio
89.6%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
18.8%
This company
18.4%
Market median
+2% vs market
20212025
Net profit margin
23.6%
This company
8.1%
Market median
+191% vs market
20212025
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SA | Audit | 2020 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aspeca AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Anna-Lena Persson | Audit | 0 companies |
| Ulf Lage Holmström | Deputy Board Member | 0 companies |
| Carl Håkan Zandén | Deputy Board Member | 0 companies |
| Eva Caroline Andersson Wilks | Board of Directors | 0 companies |